撤稿声明：Nesfatin-1/核结合蛋白-2是一种有效的预后标志物，可增强膀胱癌的细胞增殖、迁移和侵袭能力。
RETRACTION: Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer.
作者信息
Markers Disease
出版信息
Dis Markers. 2025 Apr 26;2025:9803765. doi: 10.1155/dim/9803765. eCollection 2025.
Abstract
[This retracts the article DOI: 10.1155/2018/4272064.].
摘要
[本文撤回文章DOI: 10.1155/2018/4272064。]
相似文献
1
RETRACTION: Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer.撤稿声明：Nesfatin-1/核结合蛋白-2是一种有效的预后标志物，可增强膀胱癌的细胞增殖、迁移和侵袭能力。
Dis Markers. 2025 Apr 26;2025:9803765. doi: 10.1155/dim/9803765. eCollection 2025.
2
Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer.神经降压素-1/核蛋白结合蛋白-2 是一种强有力的预后标志物，并增强膀胱癌中的细胞增殖、迁移和侵袭。
Dis Markers. 2018 Sep 19;2018:4272064. doi: 10.1155/2018/4272064. eCollection 2018.
3
Nucleobindin-2/nesfatin-1 enhances the cell proliferation, migration, invasion and epithelial-mesenchymal transition in gastric carcinoma.核结合蛋白 2/nesfatin-1 增强胃癌细胞的增殖、迁移、侵袭和上皮间质转化。
J Cell Mol Med. 2022 Oct;26(19):4986-4994. doi: 10.1111/jcmm.17522. Epub 2022 Sep 6.
4
Nucleobindin-2/Nesfatin-1-A New Cancer Related Molecule?核结合蛋白 2/内脂素-1—一种新的癌症相关分子？
Int J Mol Sci. 2021 Aug 2;22(15):8313. doi: 10.3390/ijms22158313.
5
Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.在结肠癌中，Nesfatin-1/核结合蛋白-2通过LKB1/AMPK/TORC1/ZEB1信号通路增强细胞迁移、侵袭及上皮-间质转化。
Oncotarget. 2016 May 24;7(21):31336-49. doi: 10.18632/oncotarget.9140.
6
Knockdown of Endogenous Nucb2/Nesfatin-1 in the PVN Leads to Obese-Like Phenotype and Abolishes the Metformin- and Stress-Induced Thermogenic Response in Rats.PVN 中内源性 Nucb2/Nesfatin-1 的敲低导致肥胖样表型，并消除了二甲双胍和应激引起的大鼠产热反应。
Horm Metab Res. 2022 Nov;54(11):768-779. doi: 10.1055/a-1926-7280. Epub 2022 Oct 4.
7
Endogenous NUCB2/Nesfatin-1 Regulates Energy Homeostasis Under Physiological Conditions in Male Rats.内源性 NUCB2/Nesfatin-1 在雄性大鼠生理条件下调节能量稳态。
Horm Metab Res. 2020 Sep;52(9):676-684. doi: 10.1055/a-1196-2059. Epub 2020 Jul 28.
8
Retraction: long noncoding RNA ATB promotes proliferation, migration, and invasion in bladder cancer by suppressing microRNA-126.撤回声明：长链非编码RNA ATB通过抑制微小RNA-126促进膀胱癌的增殖、迁移和侵袭。
Oncol Res. 2024 Oct 16;32(11):1819. doi: 10.32604/or.2024.056893. eCollection 2024.
9
Novel lncRNA LINC01614 Facilitates Bladder Cancer Proliferation, Migration and Invasion Through the miR-217/RUNX2/Wnt/β-Catenin Axis [Retraction].新型长链非编码RNA LINC01614通过miR-217/RUNX2/ Wnt/β-连环蛋白轴促进膀胱癌的增殖、迁移和侵袭[撤回]
Cancer Manag Res. 2022 Jun 23;14:2105-2106. doi: 10.2147/CMAR.S379380. eCollection 2022.
10
Retraction: Long non-coding RNA MEG3 inhibits cell proliferation, migration, invasion and enhances apoptosis in non-small cell lung cancer cells by regulating the miR-31-5p/TIMP3 axis.撤稿声明：长链非编码RNA MEG3通过调节miR-31-5p/TIMP3轴抑制非小细胞肺癌细胞的增殖、迁移、侵袭并增强其凋亡。
RSC Adv. 2021 Feb 1;11(10):5701. doi: 10.1039/d1ra90065j. eCollection 2021 Jan 28.
本文引用的文献
1
KIF20B Promotes Cell Proliferation and May Be a Potential Therapeutic Target in Pancreatic Cancer.驱动蛋白家族成员20B（KIF20B）促进细胞增殖，可能是胰腺癌的潜在治疗靶点。
J Oncol. 2021 Sep 9;2021:5572402. doi: 10.1155/2021/5572402. eCollection 2021.
2
Identification of Kinesin Family Member 2A (KIF2A) as a Promising Therapeutic Target for Osteosarcoma.鉴定驱动蛋白家族成员 2A（KIF2A）为骨肉瘤有前途的治疗靶点。
Biomed Res Int. 2020 Oct 29;2020:7102757. doi: 10.1155/2020/7102757. eCollection 2020.
3
Suppression of KIF22 Inhibits Cell Proliferation and Xenograft Tumor Growth in Tongue Squamous Cell Carcinoma.抑制 KIF22 可抑制舌鳞状细胞癌的细胞增殖和异种移植肿瘤生长。
Biomed Res Int. 2020 Jan 21;2020:6387545. doi: 10.1155/2020/6387545. eCollection 2020.
4
Adenylate kinase 4 promotes bladder cancer cell proliferation and invasion.腺苷酸激酶 4 促进膀胱癌细胞的增殖和侵袭。
Clin Exp Med. 2019 Nov;19(4):525-534. doi: 10.1007/s10238-019-00576-5. Epub 2019 Aug 28.
5
KIF3B Promotes the Proliferation of Pancreatic Cancer.KIF3B 促进胰腺癌的增殖。
Cancer Biother Radiopharm. 2019 Aug;34(6):355-361. doi: 10.1089/cbr.2018.2716. Epub 2019 Jun 3.
6
APLNR promotes the progression of osteosarcoma by stimulating cell proliferation and invasion.APLNR 通过刺激细胞增殖和侵袭促进骨肉瘤的进展。
Anticancer Drugs. 2019 Oct;30(9):940-947. doi: 10.1097/CAD.0000000000000785.
7
KIF20B promotes the progression of clear cell renal cell carcinoma by stimulating cell proliferation.KIF20B通过刺激细胞增殖促进透明细胞肾细胞癌的进展。
J Cell Physiol. 2019 Sep;234(9):16517-16525. doi: 10.1002/jcp.28322. Epub 2019 Feb 25.
8
CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer.CD164 促进膀胱癌的进展并预测其不良预后。
Cancer Med. 2018 Aug;7(8):3763-3772. doi: 10.1002/cam4.1607. Epub 2018 Jul 18.
Zotero 插件